Extras
Recently, I helped to organize a gathering aimed at accelerating innovation in the pharmaceutical and biotech industries. The reason for doing that should be apparent. If new medicines can be developed faster, more lives can be saved, and the quality of life can be improved.
Sadly, the opposite is occurring. It costs more money and takes more time to develop new drugs than in the past, and the chances of success are slimmer. Depressed stock market prices for the shares of even the best pharmaceutical companies tell the story.
To make the meetings interesting, we invited high-level scientists and, in addition, business leaders. Our aim was to see if innovative business leaders might prod the scientists into coming up with new ways of going about their chores.
For the complete article, join now
Enjoy the Full Value of Briefings Online
The Korn/Ferry Institute’s Briefings offers distinguished narrative on topical issues, which draw on groundbreaking research from the firm’s unparalleled expertise and pre-eminent behavioural research library. The magazine’s website also serves as an exclusive destination for executives to convene and hone their leadership skills.
Become a Premium Member Today
With a Premium Membership to The Korn/Ferry Institute’s Briefings on Talent & Leadership, you’ll have exclusive access to insights from top thinkers and leaders on business strategies and the key talent management issues that executives are facing today.
